Results From the Partnership for Advancement in Neuromodulation Registry: A 24-Month Follow-Up

Deer, Timothy R.; Skaribas, Ioannis; McJunkin, Tory; Nelson, Christopher Lee; Salmon, John F.; Darnule, Amit; Braswell, John; Russo, Marc; Gomezese, Omar Fernando

doi:10.1111/ner.12378

Cited by 16 publications

(11 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With regards to the data generated in this study, cervical SCS was found to be an efficacious treatment option for C‐FBSS. Not only are these findings consistent with other reports on cervical SCS , but also comparable (and potentially superior) to more established diagnoses such as FBSS and CRPS, as described earlier.…”

Section: Discussionsupporting

confidence: 91%

“…SCS is considered an appropriate and efficacious treatment option for a number of overlapping diagnoses between the cervical and lumbar spine: radiculopathy , CRPS , neuropathic pain . It is this overlap that gives neuromodulators the confidence to use SCS on other less established indications where there may be little evidence to support such use.…”

Section: Discussionmentioning

confidence: 99%

“…Data were collected and combined from two previously published institutional review board‐approved, prospective, multicenter registries—the EMPOWER and PAIN registry studies (Abbott, formerly St. Jude Medical). All patients treated with SCS in this study were done so utilizing standard tonic programming algorithms, at or under 1500 Hz.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series

Hunter

Carlson

Yang

et al. 2018

Neuromodulation: Technology at the Neural Interface

Self Cite

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series

Hunter

Carlson

Yang

et al. 2018

Neuromodulation: Technology at the Neural Interface

Self Cite

View full text Add to dashboard Cite

“…Quite often, however, these records and results are not made public. Many of these approaches have been used to assess ongoing safety of neuromodulation devices (12,(22)(23)(24)(25) and are synthesized in clinical consensus recommendations, such as those published by the Neuromodulation Appropriate Use Consensus Committee (NACC) (26)(27)(28).…”

Section: Introductionmentioning

confidence: 99%

Safety Analysis of Dorsal Root Ganglion Stimulation in the Treatment of Chronic Pain

Deer

Pope

Hunter

et al. 2020

Neuromodulation: Technology at the Neural Interface

Self Cite

View full text Add to dashboard Cite

Background Stimulation of the dorsal root ganglion (DRG) in the treatment of chronic, intractable pain has shown excellent clinical results in multiple published studies, including a large prospective, randomized, controlled trial. Both safety and efficacy have been demonstrated utilizing this therapeutic approach for many chronic complaints. Continued assessment of neuromodulation therapies, such as DRG stimulation, are not only an important aspect of vigilant care, but are also necessary for the evaluation for safety. Materials and Methods Safety and complaint records for DRG and spinal cord stimulation (SCS) stimulation were obtained from the manufacturer, analyzed and compiled to further assess ongoing device safety. Complaint event data were stratified according to complain type as well as overall rates. Data from similar time periods were compared between epidural neurostimulation devices by the same manufacturer as well as rates reported in the literature. Results Overall, DRG stimulation device event rates were lower or comparable to similar epidurally placed neurostimulation devices. Rates of events varied from 0 to 1.0% for DRG stimulation (n >500+ implants) which was similar to the event rate for SCS by the same manufacturer (n >2000+ implants). In comparison, complaints and adverse events ranged from 0 to 14% for SCS in the literature. Discussions The current results from a large consecutive cohort obtained from manufacturer records indicates that DRG stimulation demonstrates an excellent safety profile. Reported event rates are similar to previously reported adverse event and complaint rates in the literature for this therapy. Similarly, safety events rates were lower or similar to previously reported rates for SCS, further demonstrating the comparative safety of this neuromodulation technique for chronic pain treatment.

show abstract

“…A total of 19 studies met inclusion criteria (online supplementary file 1). 2 7–24 All 19 studies reported current smoking and 2 studies2 21 reported former smoking. Three studies were randomized controlled trials (RCTs),13 21 24 six studies were prospective cohort studies,7–9 11 15 16 nine studies were retrospective cohort studies2 10 12 14 17–20 23 and one study was a cross-sectional study 22.…”

Section: Resultsmentioning

confidence: 99%

Prevalence of smoking in adults with spinal cord stimulators: a systematic review and meta-analysis

Hooten

Moman

Dvorkin³

et al. 2020

Reg Anesth Pain Med

View full text Add to dashboard Cite

BackgroundSmoking adversely impacts pain-related outcomes of spinal cord stimulation (SCS). However, the proportion of SCS patients at risk of worse outcomes is limited by an incomplete knowledge of smoking prevalence in this population. Thus, the primary aim of this systematic review is to determine the prevalence of smoking in adults with chronic pain treated with SCS.MethodsA comprehensive search of databases from 1 January 1980 to 3 January 2019 was conducted. Eligible study designs included (1) randomized trials; (2) prospective and retrospective cohort studies; and (3) cross-sectional studies. The risk of bias was assessed using a tool specifically developed for prevalence studies. A total of 1619 records were screened, 19 studies met inclusion criteria, and the total number of participants was 10 838.ResultsThirteen studies had low or moderate risk of bias, and six had a high risk of bias. All 19 studies reported smoking status and the pooled prevalence was 38% (95% CI 30% to 47%). The pooled prevalence in 6 studies of peripheral vascular diseases was 56% (95% CI 42% to 69%), the pooled prevalence of smoking in 11 studies of lumbar spine diagnoses was 28% (95% CI 20% to 36%) and the pooled prevalence in 2 studies of refractory angina was 44% (95% CI 31% to 58%).ConclusionsThe estimated prevalence of smoking in SCS patients is 2.5 times greater than the general population. Future research should focus on development, testing and deployment of tailored smoking cessation treatments for SCS patients.

show abstract

Results From the Partnership for Advancement in Neuromodulation Registry: A 24-Month Follow-Up

Cited by 16 publications

References 11 publications

Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series

Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series

Safety Analysis of Dorsal Root Ganglion Stimulation in the Treatment of Chronic Pain

Prevalence of smoking in adults with spinal cord stimulators: a systematic review and meta-analysis

Contact Info

Product

Resources

About